Riviere Y, Montange T, Janvier G, Marnata C, Durrieu L, Chaix M
Virol J. 2012; 9:76.
PMID: 22455516
PMC: 3369207.
DOI: 10.1186/1743-422X-9-76.
Nair S, Bayer W, Ploquin M, Kassiotis G, Hasenkrug K, Dittmer U
Retrovirology. 2011; 8:76.
PMID: 21943070
PMC: 3193819.
DOI: 10.1186/1742-4690-8-76.
Puissant-Lubrano B, Bossi P, Gay F, Crance J, Bonduelle O, Garin D
J Clin Invest. 2010; 120(5):1636-44.
PMID: 20364089
PMC: 2860918.
DOI: 10.1172/JCI38506.
Chattopadhyay P, Betts M, Price D, Gostick E, Horton H, Roederer M
J Leukoc Biol. 2008; 85(1):88-97.
PMID: 18820174
PMC: 2638730.
DOI: 10.1189/jlb.0208107.
Rodriguez M, Zoecklein L, Kerkvliet J, Pavelko K, Papke L, Howe C
J Virol. 2008; 82(7):3369-80.
PMID: 18234804
PMC: 2268466.
DOI: 10.1128/JVI.02243-07.
Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation.
Casazza J, Betts M, Price D, Precopio M, Ruff L, Brenchley J
J Exp Med. 2006; 203(13):2865-77.
PMID: 17158960
PMC: 2118179.
DOI: 10.1084/jem.20052246.
The physiological role of cytotoxic CD4(+) T-cells: the holy grail?.
Appay V
Clin Exp Immunol. 2004; 138(1):10-3.
PMID: 15373899
PMC: 1809194.
DOI: 10.1111/j.1365-2249.2004.02605.x.
Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T cells.
Norris P, Moffett H, Yang O, Kaufmann D, Clark M, Addo M
J Virol. 2004; 78(16):8844-51.
PMID: 15280492
PMC: 479080.
DOI: 10.1128/JVI.78.16.8844-8851.2004.
Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunization.
Venturini S, Mosier D, Burton D, Poignard P
J Virol. 2002; 76(14):6987-99.
PMID: 12072499
PMC: 136330.
DOI: 10.1128/jvi.76.14.6987-6999.2002.
Multiple effector functions mediated by human immunodeficiency virus-specific CD4(+) T-cell clones.
Norris P, Sumaroka M, Brander C, Moffett H, Boswell S, Nguyen T
J Virol. 2001; 75(20):9771-9.
PMID: 11559810
PMC: 114549.
DOI: 10.1128/JVI.75.20.9771-9779.2001.
T-cell receptor-mediated anergy of a human immunodeficiency virus (HIV) gp120-specific CD4(+) cytotoxic T-cell clone, induced by a natural HIV type 1 variant peptide.
Bouhdoud L, Villain P, Merzouki A, Arella M, Couture C
J Virol. 2000; 74(5):2121-30.
PMID: 10666241
PMC: 111692.
DOI: 10.1128/jvi.74.5.2121-2130.2000.
Epstein-Barr virus-transformed B cells, a potentially convenient source of autologous antigen-presenting cells for the propagation of certain human cytotoxic T lymphocytes.
Purner M, Berens R, Krug E, Curiel T
Clin Diagn Lab Immunol. 1994; 1(6):696-700.
PMID: 8556523
PMC: 368394.
DOI: 10.1128/cdli.1.6.696-700.1994.
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
Koup R, Safrit J, Cao Y, Andrews C, McLeod G, Borkowsky W
J Virol. 1994; 68(7):4650-5.
PMID: 8207839
PMC: 236393.
DOI: 10.1128/JVI.68.7.4650-4655.1994.
Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins.
McGuire T, Tumas D, Byrne K, Hines M, Leib S, Brassfield A
J Virol. 1994; 68(3):1459-67.
PMID: 8107209
PMC: 236601.
DOI: 10.1128/JVI.68.3.1459-1467.1994.
Cytotoxic activity against maedi-visna virus-infected macrophages.
Lee W, McConnell I, Blacklaws B
J Virol. 1994; 68(12):8331-8.
PMID: 7966626
PMC: 237302.
DOI: 10.1128/JVI.68.12.8331-8338.1994.
Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens.
Jassoy C, Harrer T, Rosenthal T, Navia B, Worth J, Johnson R
J Virol. 1993; 67(5):2844-52.
PMID: 7682629
PMC: 237609.
DOI: 10.1128/JVI.67.5.2844-2852.1993.
Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein.
Buseyne F, McChesney M, Porrot F, KOVARIK S, Guy B, Riviere Y
J Virol. 1993; 67(2):694-702.
PMID: 7678303
PMC: 237420.
DOI: 10.1128/JVI.67.2.694-702.1993.
Oestrogen influences CD4+ T-lymphocyte activity in vivo and in vitro in beta 2-microglobulin-deficient mice.
Muller D, Chen M, Vikingsson A, Hildeman D, Pederson K
Immunology. 1995; 86(2):162-7.
PMID: 7490113
PMC: 1383990.
Identification of T-cell epitopes on E2 protein of rubella virus, as recognized by human T-cell lines and clones.
Ou D, Chong P, Choi Y, McVeigh P, Jefferies W, Koloitis G
J Virol. 1992; 66(11):6788-93.
PMID: 1383570
PMC: 240179.
DOI: 10.1128/JVI.66.11.6788-6793.1992.
Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A24-restricted cytotoxic T lymphocytes.
Dai L, West K, Littaua R, Takahashi K, Ennis F
J Virol. 1992; 66(5):3151-4.
PMID: 1373204
PMC: 241078.
DOI: 10.1128/JVI.66.5.3151-3154.1992.